Search Results

You are looking at 1 - 2 of 2 items for :

  • Radioiodine therapy x
  • Goiter and thyroid nodules x
Clear All
Cosimo Durante Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy

Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Close
,
Laszlo Hegedüs Department of Endocrinology, Odense University Hospital, Odense, Denmark

Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Close
,
Agnieszka Czarniecka M. Sklodowska-Curie National Research, Institute of Oncology Gliwice Branch, Gliwice, Poland

Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Close
,
Ralf Paschke Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close
,
Gilles Russ Thyroid and Endocrine Tumors Department, Pitié-Salpêtrière Hospital, Sorbonne University GRC N°16, Paris, France

Search for other papers by Gilles Russ in
Google Scholar
PubMed
Close
,
Fernando Schmitt Faculty of Medicine of University of Porto, CINTESIS@RISE and Institute of Molecular Pathology and Immunology, University of Porto (Ipatimup), Porto, Portugal

Search for other papers by Fernando Schmitt in
Google Scholar
PubMed
Close
,
Paula Soares Institute of Investigation and Innovation in Health (I3S), Faculty of Medicine of the University of Porto, Porto, Portugal

Search for other papers by Paula Soares in
Google Scholar
PubMed
Close
,
Tamas Solymosi Endocrinology and Metabolism Clinic, Bugat Hospital, Gyöngyös, Hungary

Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Close
, and
Enrico Papini Department of Endocrine and Metabolic Diseases, Regina Apostolorum Hospital, Albano, Rome, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed
Close

for management (paragraph ‘Radioiodine therapy’). 7) In case of clinical or US suspicion of chronic lymphocytic thyroiditis and negative TPOAb, Tg antibody determination may be considered. EU-TIRADS, European Thyroid Imaging and Reporting Data System

Open access
Aglaia Kyrilli Department of Endocrinology, Hôpital Universitaire de Bruxelles (H.U.B.)– Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, Brussels, Belgium

Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Close
,
Nunzia Tacelli Department of Radiology, Hôpital Universitaire de Bruxelles (H.U.B.)– Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, Brussels, Belgium

Search for other papers by Nunzia Tacelli in
Google Scholar
PubMed
Close
,
Lucia Russo Department of Medicine, DIMED, Internal Medicine 3, University of Padua, Via Giustiniani 2, 35128, Padova, Italy

Search for other papers by Lucia Russo in
Google Scholar
PubMed
Close
,
Laetitia Lebrun Department of Pathology, Hôpital Universitaire de Bruxelles (H.U.B.)– Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, Brussels, Belgium

Search for other papers by Laetitia Lebrun in
Google Scholar
PubMed
Close
,
Isabelle Salmon Department of Pathology, Hôpital Universitaire de Bruxelles (H.U.B.)– Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, Brussels, Belgium

Search for other papers by Isabelle Salmon in
Google Scholar
PubMed
Close
,
Gilles Russ Thyroid and Endocrine Tumors, Institute of Endocrinology, Pitié Salpêtrière Hospital, Pierre et Marie Curie University, Paris, France

Search for other papers by Gilles Russ in
Google Scholar
PubMed
Close
,
Rodrigo Moreno-Reyes Department of Nuclear Medicine, Hôpital Universitaire de Bruxelles (H.U.B.)– Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik, Brussels, Belgium

Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Close
, and
Bernard Corvilain Department of Endocrinology, Hôpital Universitaire de Bruxelles (H.U.B.)– Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, Brussels, Belgium

Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Close

solid areas. The other exclusion criteria were pregnancy or lactation, active malignancy, uncontrolled concomitant disease requiring further clinical investigation, previous radioiodine therapy, recent administration of iodine-contrast media, current

Open access